Cognitive Impairment Associated with Schizophrenia: a Review of the Humanistic Burden

被引:56
|
作者
Kitchen, Helen [1 ]
Rofail, Diana
Heron, Louise
Sacco, Pat [2 ]
机构
[1] Adelphi Mill, Adelphi Values, Bollington SK10 5JB, Cheshire, England
[2] Novartis Pharmaceut, E Hanover, NJ USA
关键词
burden; cognitive impairment associated with schizophrenia; conceptual model; cost; humanistic; patient reported outcome; schizophrenia; QUALITY-OF-LIFE; ANTIPSYCHOTIC MEDICATIONS; 2ND-GENERATION ANTIPSYCHOTICS; CONVENTIONAL ANTIPSYCHOTICS; 1ST-EPISODE SCHIZOPHRENIA; ATYPICAL ANTIPSYCHOTICS; EXECUTIVE FUNCTION; NEGATIVE SYMPTOMS; ECONOMIC BURDEN; UNITED-STATES;
D O I
10.1007/s12325-012-0001-4
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Introduction: Nearly every individual with schizophrenia is affected by cognitive decline. The aim of this literature review was to: (a) describe the humanistic burden of cognitive impairment associated with schizophrenia (CIAS); (b) develop a conceptual model that depicts the signs and symptoms of CIAS along with key concepts important to patients; and (c) consider the adequacy of potential patient-reported outcome (PRO) instruments for assessing future treatments. Methods: The following electronic databases were searched for articles published between January 1999 and November 2009 related to CIAS and PROs, or cost of illness: Medline; Embase; PsycINFO; the Health Economic Evaluation Database; and the National Health Service Economic Evaluation Database and Health Technology Assessment databases at the Centre for Reviews and Dissemination, University of York. Results: The literature search revealed 3950 abstracts, of which 101 articles were reviewed in detail. Cognitive functions affected include memory, attention/concentration, problem solving, learning, executive function, processing speed, and social cognition. Cognitive impairment impacts the ability of individuals to carry out activities of daily living, work productively, function socially, and adhere to treatment. These effects have economic ramifications through increased direct and indirect costs associated with the treatment of schizophrenia. The literature revealed 39 PRO instruments that have been used to assess functioning. However, no single instrument captures all key concepts of importance to patients with schizophrenia. Conclusion: The significant burden from CIAS for patients and society has implications for designing future treatments and health strategies to improve functional outcomes.
引用
收藏
页码:148 / 162
页数:15
相关论文
共 50 条
  • [31] Psychiatric and functional correlates of stigma associated with cognitive impairment in schizophrenia
    Gonzales, Lauren
    Saperstein, Alice M.
    Qian, Min
    Gorecki, Adam
    Medalia, Alice
    PSYCHIATRY RESEARCH, 2024, 342
  • [32] Glymphatic System Dysfunction Underlying Schizophrenia Is Associated With Cognitive Impairment
    Tu, Ye
    Fang, Yan
    Li, Guohui
    Xiong, Fei
    Gao, Feng
    SCHIZOPHRENIA BULLETIN, 2024, 50 (05) : 1223 - 1231
  • [33] Low BDNF is associated with cognitive impairment in chronic patients with schizophrenia
    Xiang Yang Zhang
    Jun Liang
    Da Chun Chen
    Mei Hong Xiu
    Fu De Yang
    Therese A. Kosten
    Thomas R. Kosten
    Psychopharmacology, 2012, 222 : 277 - 284
  • [34] Low BDNF is associated with cognitive impairment in chronic patients with schizophrenia
    Zhang, Xiang Yang
    Liang, Jun
    Chen, Da Chun
    Xiu, Mei Hong
    Yang, Fu De
    Kosten, Therese A.
    Kosten, Thomas R.
    PSYCHOPHARMACOLOGY, 2012, 222 (02) : 277 - 284
  • [35] Intracellular Signaling and Approaches to the Treatment of Schizophrenia and Associated Cognitive Impairment
    Snyder, Gretchen L.
    Vanover, Kimberly E.
    CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (31) : 5093 - 5103
  • [36] New clues for the role of cerebellum in schizophrenia and the associated cognitive impairment
    Faris, Pawan
    Pischedda, Doris
    Palesi, Fulvia
    D'Angelo, Egidio
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2024, 18
  • [37] The awareness, characterization, and burden of Cognitive Impairment Associated with Schizophrenia (CIAS) in clinical practice: Results from a nationwide survey in Italy
    Vita, Antonio
    Barlati, Stefano
    Cavallaro, Roberto
    Cipelli, Riccardo
    Corrivetti, Giulio
    Delmonte, Dario
    Lusito, Eleonora
    Maia, Elisabetta
    Marino, Maria Michela
    Nicolo, Giuseppe
    Rocca, Paola
    Galderisi, Silvana
    SCHIZOPHRENIA RESEARCH-COGNITION, 2025, 40
  • [38] CLINICAL OUTCOME ASSESSMENTS FOR TRIALS IN COGNITIVE IMPAIRMENT ASSOCIATED WITH SCHIZOPHRENIA
    Edgar, Christopher
    Maruff, Paul
    SCHIZOPHRENIA BULLETIN, 2019, 45 : S213 - S213
  • [39] Montreal Cognitive Assessment for evaluating the cognitive impairment in patients with schizophrenia: A systematic review
    Rosca, Elena Cecilia
    Cornea, Amalia
    Simu, Mihaela
    GENERAL HOSPITAL PSYCHIATRY, 2020, 65 : 64 - 73
  • [40] A SYSTEMATIC LITERATURE REVIEW OF THE HUMANISTIC BURDEN OF ANAEMIA ASSOCIATED WITH CHRONIC KIDNEY DISEASE
    Rizzo, Maria
    Iheanacho, Ike
    Van Nooten, Floortje E.
    Goldsmith, David
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 404 - 405